Clinical Pharmacology & Biopharmaceutics
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 1089
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Effect of omega 3 fatty acids on cardiac necrosis biomarkers creatine kinase-MB and troponin-I in chronic kidney disease patients undergoing percutaneous coronary intervention
Pharma Middle East
Maryam Forouzmehr and Farzaneh Foroughinia
Shiraz University of Medical Sciences, Iran
Posters-Accepted Abstracts: Clin Pharmacol Biopharm
DOI:
Abstract
Objectives: To assess the effect of omega 3 fatty acids on cardiac necrosis biomarkers CK-MB and Troponin-I in Chronic Kidney Disease (CKD) patients undergoing elective Percutaneous Coronary Intervention (PCI). Background: Coronary artery diseases are the leading cause of mortality in CKD patients. In recent studies, it is shown that elevation in cardiac necrosis biomarkers, creatine kinase-MB (CK-MB) and troponin-I, have direct relation with increased cardiovascular risks following PCI in CKD patients. Methods: In this study, 50 CKD patients undergoing elective PCI were randomly assigned into two groups. First group received a loading dose (3 gr) of omega 3, 12 hours prior to intervention plus the standard PCI regimen (aspirin 80 mg and clopidogrel 600 mg loading then 75 mg/day). Second group received only the standard PCI regimen. The CK-MB and troponin-I levels were measured at baseline and 24 h after PCI. Results: A significant decreasing trend in CK-MB level (p=0.0021) and troponin-I level (p=0.004) was seen in omega 3 group versus control group after PCI. Conclusion: A 3 gr loading dose of omega 3 before PCI significantly reduces CK-MB and troponin-I after PCI in CKD patients.Biography
Maryam Forouzmehr is student at the Shiraz University of Medical Sciences, School of Pharmacy. She is working on her thesis and will graduate this year with PharmD degree.
Email: mforouzmehr@gmail.com
